Enriched Astaxanthin Extract from Haematococcus pluvialis Augments Growth Factor Secretions to Increase Cell Proliferation and Induces MMP1 Degradation to Enhance Collagen Production in Human Dermal Fibroblasts.
Among many antioxidants that are used for the repairing of oxidative stress induced skin damages, we identified the enriched astaxanthin extract (EAE) from Haematococcus pluvialis as a viable ingredient. EAE was extracted from the red microalgae through supercritical fluid carbon dioxide extraction. To compare the effectiveness, EAE wastreated on human dermal fibroblasts with other components, phorbol 12-myristate 13-acetate (PMA), and doxycycline. With sirius red staining and quantitative real-time polymerase chain reaction (qRT-PCR), we found that PMA decreased the collagen concentration and production while overall the addition of doxycycline and EAE increased the collagen concentration in a trial experiments. EAE increased collagen contents through inhibited MMP1 and MMP3 mRNA expression and induced TIMP1, the antagonists of MMPs protein, gene expression. As for when tested for various proteins through western blotting, it was seen that the addition of EAE increased the expression of certain proteins that promote cell proliferation. Testing those previous solutions using growth factor assay, it was noticeable that EAE had a positive impact on cell proliferation and vascular endothelial growth factor (VEGF) than doxycycline, indicating that it was a better alternative treatment for collagen production. To sum up, the data confirmed the possible applications as medical cosmetology agentsand food supplements.
Department of Fragrance and Cosmetic Science, Kaohsiung Medical University, Kaohsiung 807, Taiwan. s9412105@yahoo.com.tw.|Division of Biochemistry and Molecular Biology, Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan. s9412105@yahoo.com.tw.
Hsin-Yu
HY
Chou
Department of Psychology, Michigan State University, East Lansing, MI 48824, USA. chejlee@umich.edu.
Chelsea
C
Lee
Department of Applied Cosmetology, Kao Yuan University, Kaohsiung 821, Taiwan. t50050@cc.kyu.edu.tw.|Degree Program of Cosmetology and Health Care, Kao Yuan University, Kaohsiung 821, Taiwan. t50050@cc.kyu.edu.tw.
Jian-Liang
JL
Pan
Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung 804, Taiwan. wzh@mail.nsysu.edu.tw.
Zhi-Hong
ZH
Wen
Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan. huangsh63@gmail.com.|Division of Plastic Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan. huangsh63@gmail.com.|Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan. huangsh63@gmail.com.|Center for Stem Cell Research, Kaohsiung Medical University, Kaohsiung 807, Taiwan. huangsh63@gmail.com.
Shu-Hung
SH
Huang
Biorefinery &amp; Bioprocess Engineering Laboratory, Department of Chemical Engineering and Materials Science, Yuan Ze University, Chung-Li 320, Taiwan. lanchiwei@saturn.yzu.edu.tw.
Chi-Wei John
CW
Lan
Department of Biotechnology, Kaohsiung Medical University, Kaohsiung 807, Taiwan. liuwangta@kmu.edu.tw.
Wang-Ta
WT
Liu
Division of Biochemistry and Molecular Biology, Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan. cliff@cc.kmu.edu.tw.|Department of Biochemistry, School of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan. cliff@cc.kmu.edu.tw.
Tzyh-Chyuan
TC
Hour
Department of Cosmeceutics, College of Biopharmaceutical and Food Sciences, China Medical University, Taichung 40402, Taiwan. ychseu@mail.cmu.edu.tw.|Department of Health and Nutrition Biotechnology, Asia University, Taichung 41354, Taiwan. ychseu@mail.cmu.edu.tw.
You-Cheng
YC
Hseu
Division of Bioengineering, Incheon National University, Incheon 22012, Korea. bhwang@inu.ac.kr.
Byeong Hee
BH
Hwang
Department of Internal Medicine, Chi-Mei Medical Center, Tainan 710, Taiwan. kcg.cheng@gmail.com.|Department of Safety Health and Environment, Chung Hwa University of Medical Technology, Tainan 717, Taiwan. kcg.cheng@gmail.com.|Department of Medicine, National Defense Medical Center, Taipei 114, Taiwan. kcg.cheng@gmail.com.
Kuo-Chen
KC
Cheng
Department of Fragrance and Cosmetic Science, Kaohsiung Medical University, Kaohsiung 807, Taiwan. davidw@kmu.edu.tw.|Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung 804, Taiwan. davidw@kmu.edu.tw.|Center for Stem Cell Research, Kaohsiung Medical University, Kaohsiung 807, Taiwan. davidw@kmu.edu.tw.|Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung 807, Taiwan. davidw@kmu.edu.tw.|Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung 807, Taiwan. davidw@kmu.edu.tw.
Hui-Min David
HM
Wang
D000975:Antioxidants / Q000494:pharmacology; D001713:Biphenyl Compounds / Q000037:antagonists & inhibitors; D049109:Cell Proliferation / Q000187:drug effects; D000460:Chlorophyta / Q000737:chemistry*; D003094:Collagen / Q000096:biosynthesis*; D020405:Dermis / Q000166:cytology*; D005347:Fibroblasts / Q000187:drug effects* / Q000378:metabolism*; D016166:Free Radical Scavengers / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism*; D007502:Iron Chelating Agents / Q000494:pharmacology; D020781:Matrix Metalloproteinase 1 / Q000235:genetics / Q000378:metabolism*; D010851:Picrates / Q000037:antagonists & inhibitors; D010936:Plant Extracts / Q000494:pharmacology*; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
D000975:Antioxidants; D001713:Biphenyl Compounds; D016166:Free Radical Scavengers; D036341:Intercellular Signaling Peptides and Proteins; D007502:Iron Chelating Agents; D010851:Picrates; D010936:Plant Extracts; D042461:Vascular Endothelial Growth Factor A; D003094:Collagen; C004931:1,1-diphenyl-2-picrylhydrazyl; D020781:Matrix Metalloproteinase 1
Haematococcus pluvialis; doxycycline; enriched astaxanthin extract (EAE); phorbol 12-myristate 13-acetate (PMA)